Literature DB >> 11545637

Validation of a diagnostic multiplex polymerase chain reaction assay for infectious posterior uveitis.

H Dabil1, M L Boley, T M Schmitz, R N Van Gelder.   

Abstract

OBJECTIVE: To validate a multiplex polymerase chain reaction (PCR) assay capable of simultaneously screening vitreous biopsy specimens for a panel of common pathogens in posterior uveitis.
METHODS: A multiplex PCR assay using novel primer sets for cytomegalovirus (CMV), herpes simplex virus (HSV), varicella zoster virus (VZV), and Toxoplasma gondii was developed. The sensitivity of the assay was determined for purified pathogen DNA. Twenty-one vitreous specimens from patients with posterior uveitis were tested by both multiplex and monoplex PCR.
RESULTS: Fewer than 10 genomes of VZV and fewer than 100 genomes of HSV, CMV, and T gondii could be detected using the new primer sets. When used in multiplex, the assay lost less than 1 log of sensitivity. Monoplex PCR detected pathogen DNA in 18 of 21 patient samples; multiplex PCR detected pathogen DNA in 15 of the 18 samples positive by monoplex PCR. None of 10 negative control samples were positive for pathogen DNA.
CONCLUSIONS: Multiplex PCR has adequate sensitivity to simultaneously screen a substantial differential diagnosis for posterior uveitis in a single reaction, without loss of specificity. This assay may reduce the time and cost involved in PCR-based molecular diagnostics of infectious pathogens. CLINICAL RELEVANCE: Mutiplex PCR may allow rapid diagnosis of infectious posterior uveitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545637     DOI: 10.1001/archopht.119.9.1315

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  18 in total

Review 1.  [Diagnostic vitrectomy in uveitis: possibilities of molecular biology].

Authors:  M D Becker; B Bodaghi; F G Holz; N Harsch; P Le Hoang
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

2.  Prevalence of herpes simplex virus, varicella zoster virus and cytomegalovirus in HIV-positive and HIV-negative patients with viral retinitis in India.

Authors:  K Priya; B Mahalakshmi; J Malathi; J Biswas; B Sukumar; H N Madhavan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-08       Impact factor: 3.267

Review 3.  Polymerase chain reaction in the diagnosis of uveitis.

Authors:  Chi-Chao Chan; DeFen Shen; Jingsheng Tuo
Journal:  Int Ophthalmol Clin       Date:  2005

4.  Prospective comparison between conventional microbial work-up vs PCR in the diagnosis of fungal keratitis.

Authors:  N Tananuvat; K Salakthuantee; N Vanittanakom; M Pongpom; S Ausayakhun
Journal:  Eye (Lond)       Date:  2012-08-10       Impact factor: 3.775

Review 5.  Advances in the management of acute retinal necrosis.

Authors:  Jessica G Shantha; Heather M Weissman; Matthew R Debiec; Thomas A Albini; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2015

6.  Role of molecular diagnostics in ocular microbiology.

Authors:  Parisa Taravati; Deborah Lam; Russell N Van Gelder
Journal:  Curr Ophthalmol Rep       Date:  2013-12-01

Review 7.  Emerging techniques for pathogen discovery in endophthalmitis.

Authors:  Bryan K Hong; Cecilia S Lee; Russell N Van Gelder; Sunir J Garg
Journal:  Curr Opin Ophthalmol       Date:  2015-05       Impact factor: 3.761

8.  Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

Authors:  Soon-Phaik Chee; Aliza Jap
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-03       Impact factor: 3.117

9.  DNA chip-assisted diagnosis of a previously unknown etiology of intermediate uveitis- Toxoplasma gondii.

Authors:  Soumyava Basu; Savitri Sharma; Sarita Kar; Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2010 Nov-Dec       Impact factor: 1.848

10.  Posterior segment findings of ocular cytomegalovirus infection in immunocompetent patients.

Authors:  Melissa H Y Wong; Gemmy C M Cheung; Soon-Phaik Chee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-24       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.